FOXP3 and neoplasm: In particular, the vaccination assay conducted in vivo demonstrated that tumour volume was 4.59-fold smaller than the control and that the ratio of immunostimulant cytotoxic T-cells (CD8+) against immunosuppressive Foxp3+ T-cells was 4.9-fold higher.